North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Valbenazine (CAS: <strong>1025504-45-3</strong>) is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor. Its molecular formula is C<sub>27</sub>H<sub>36</sub>N<sub>2</sub>O<sub>3</sub>. The compound is synthesized via complex organic pathways involving stereoselective reduction and functional group manipulation to ensure high purity for pharmaceutical use.</p>
<h3>Application</h3>
<ul>
<li><strong>Tardive Dyskinesia:</strong> Treatment of moderate-to-severe tardive dyskinesia in adults.</li>
<li><strong>Dopaminergic Regulation:</strong> Management of abnormal involuntary movements associated with antipsychotic therapy.</li>
<li><strong>Clinical Trials:</strong> Investigational use in movement disorders requiring VMAT2 modulation.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated in patients with known hypersensitivity. Monitor for QT prolongation and somnolence. Store in a cool, dry place away from direct sunlight and moisture to maintain chemical stability.</p>